US Patent Issued to Cinclus Pharma Holding on July 22 for "Polymorphs of the hydrochloride salt of linaprazan glurate" (Swedish, Chinese Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,680, issued on July 22, was assigned to Cinclus Pharma Holding AB (Publ) (Stockholm).

"Polymorphs of the hydrochloride salt of linaprazan glurate" was invented by Kjell Jarring (Lund, Sweden), Thomas Larsson (Bjarred, Sweden), Xingbang Lin (Guangdon, China), Dan Wang (Guangdong, China) and Mikael Hillgren (Uppsala, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to polymorphs of the hydrochloride salt of 5-{2-[({8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-yl}carbonyl)-amino]ethoxy}-5-oxopentanoic acid (linaprazan glurate), more specifically Form 1 and Form 2 of the HCl salt of linaprazan glu...